Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03807063
Title Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.